A carregar...

Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver

MicroRNAs (miRNAs) are important regulators and potential therapeutic targets of metabolic disease. In this study we show by in vivo administration of locked nucleic acid (LNA) inhibitors that suppression of endogenous miR-29 lowers plasma cholesterol levels by ~40%, commensurate with the effect of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Kurtz, C. Lisa, Fannin, Emily E., Toth, Cynthia L., Pearson, Daniel S., Vickers, Kasey C., Sethupathy, Praveen
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526858/
https://ncbi.nlm.nih.gov/pubmed/26246194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep12911
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!